Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at effekten og sikkerheden af NutropinAq generelt svarer til andre rekombinante humane lægemidler med værkshormon.
The Committee for Medicinal products for Human Use (CHMP) concluded that the effectiveness and safety of NutropinAq are generally comparable to that of other recombinant human growth hormone medicines.